BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Cash Flow Reinvestment Rate
BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Cash Flow Reinvestment Rate of 0.83x as of September 2025, reinvesting Rs123.88 Million (capex Rs123.88 Million ) from operating cash flow of Rs149.66 Million. Explore BALAXI capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BALAXI PHARMACEUTICALS LIMITED Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for BALAXI PHARMACEUTICALS LIMITED across 6 annual periods. Also explore BALAXI total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for BALAXI PHARMACEUTICALS LIMITED (2013–2024)
Year-by-year capital reinvestment analysis for BALAXI PHARMACEUTICALS LIMITED. For live market cap and broader valuation context, see market value of BALAXI PHARMACEUTICALS LIMITED.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.54x | Rs26.16 Million | Rs48.66 Million | Rs15.69 Million | ▼ -87.2% |
| 2023 | 4.20x | Rs255.45 Million | Rs60.75 Million | Rs149.80 Million | ▲ +366.7% |
| 2022 | 0.90x | Rs307.61 Million | Rs341.44 Million | Rs273.44 Million | ▼ -100.0% |
| 2021 | 1926.71x | Rs59.73 Million | Rs31.00K | Rs25.56 Million | ▲ +13694722.6% |
| 2015 | 0.01x | Rs29.72K | Rs2.11 Million | Rs29.72K | — |
| 2013 | 0.00x | Rs0.00 | Rs3.25 Million | Rs0.00 | — |